市場調査レポート
商品コード
1541554
大動脈弁置換術の市場レポート:手術別、製品別、最終用途別、地域別、2024~2032年Aortic Valve Replacement Market Report by Surgery (Open Surgery, Minimally Invasive Surgery), Product (Transcatheter Aortic Valve, Sutureless Valve, and Others), End Use (Hospitals, Ambulatory Surgery Centers, and Others), and Region 2024-2032 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
大動脈弁置換術の市場レポート:手術別、製品別、最終用途別、地域別、2024~2032年 |
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 144 Pages
納期: 2~3営業日
|
世界の大動脈弁置換術の市場規模は2023年に102億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに250億米ドルに達し、2024~2032年の間に10.1%の成長率(CAGR)を示すと予測しています。大動脈疾患の有病率の増加、健康保険政策の実施率の上昇、MIS手技の採用増加などが市場を牽引する主要要因となっています。
大動脈弁置換術は、心臓の疾患または損傷した大動脈弁を置換するために行われる外科手術です。通常、胸部を切開する伝統的な開胸手術か、胸部をより小さく切開したり脚にカテーテルを挿入したりする低侵襲(MI)手術が行われます。弁に影響を及ぼす病気を治療し、心臓を通る血流をコントロールします。正常な血流を回復し、症状を軽減し、延命し、心筋の機能を維持するのに役立ちます。一般的には、大動脈弁狭窄症や大動脈弁閉鎖不全症などの重症の大動脈弁疾患で、胸痛、息切れ、疲労感などの症状がある患者に推奨されます。
大衆の間で大動脈疾患の有病率が急上昇していること、そしてこれらの医療障害を発症しやすい高齢化人口が増加していることが、世界中で大動脈弁置換術の需要を促進している主要要因の一つです。さらに、大動脈弁置換術のための経済的支援を提供し、医療費を削減する健康保険の導入が増加していることも、市場の成長を後押ししています。さらに、大動脈疾患、その症状、診断、大動脈弁置換術のような治療オプションの容易な利用可能性についての意識の高まりが、市場にプラスの影響を与えています。これとは別に、経カテーテル大動脈弁置換術(TAVR)の採用が増加しており、これは開心術なしで大動脈弁を置換するのに役立つ低侵襲手術(MIS)であり、従来の開心術に大きなリスクを伴う患者に一般的に好まれています。これは、手術合併症の少なさ、入院期間の短さ、痛みの少なさ、術後ケアの軽減、回復の早さ、感染リスクの低さを理由にMIS手技への嗜好が高まっていることと相まって、市場の成長を促進しています。さらに、大動脈弁置換術の画像診断技術に人工知能(AI)と機械学習(ML)を統合することで、合併症のリスクが高い患者を特定し、手技と術後ケアを最適化することが、市場の成長に寄与しています。このほか、多くの国の行政機関が、誰もが利用できる質の高い医療施設を提供するための対策に取り組んでいます。これに加え、診断技術の大幅な向上が市場の成長を強化しています。
The global aortic valve replacement market size reached US$ 10.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 25.0 Billion by 2032, exhibiting a growth rate (CAGR) of 10.1% during 2024-2032. The increasing prevalence of aortic diseases, rising implementation of health insurance policies, and the growing adoption of MIS procedures represent some of the key factors driving the market.
Aortic valve replacement is a surgical procedure performed to replace a diseased or damaged aortic valve in the heart. It is usually operated through the traditional open-heart surgery, which involves incising the chest or using minimally invasive (MI) methods that require smaller incisions in the chest or a catheter incorporated in the leg. It treats diseases that affect the valves and controls blood flow through the heart. It aids in restoring normal blood flow, reducing symptoms, prolonging life, and preserving the function of the heart muscle. It is generally recommended for patients with severe aortic valve disease, including aortic stenosis or aortic regurgitation, that has symptoms like chest pain, shortness of breath, and fatigue.
The surging prevalence of aortic diseases among the masses and the increasing aging population that is more prone to developing these medical disorders represent one of the major factors driving the demand for aortic valve replacement around the world. Moreover, the rising implementation of health insurance policies that offer financial assistance for aortic valve replacement and reduce medical expenses is favoring the growth of the market. In addition, the growing awareness about aortic diseases, their symptoms, diagnosis, and the easy availability of the treatment options like aortic valve replacement is influencing the market positively. Apart from this, there is an increase in the adoption of transcatheter aortic valve replacement (TAVR), minimally invasive surgical (MIS) procedure that helps replace the aortic valve without open-heart surgery and is generally preferred by patients who are at major risk for traditional open-heart surgery. This, coupled with the rising preferences for MIS procedures on account of fewer operative complications, shorter hospitalization, less pain, reduced postoperative care, quicker recovery, and lower risk of infection, is propelling the growth of the market. Furthermore, the integration of artificial intelligence (AI) and machine learning (ML) in imaging techniques of aortic valve replacement to identify patients who are at higher risk for complications and optimize the procedure and postoperative care is contributing to the market growth. Besides this, governing agencies of numerous countries are undertaking measures to offer quality healthcare facilities that are accessible to all. This, along with significant improvements in the diagnostic technologies, is strengthening the growth of the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global aortic valve replacement market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on surgery, product and end use.
Open Surgery
Minimally Invasive Surgery
The report has provided a detailed breakup and analysis of the aortic valve replacement market based on the surgery. This includes open surgery and minimally invasive surgery. According to the report, minimally invasive surgery represented the largest segment.
Transcatheter Aortic Valve
Sutureless Valve
Others
A detailed breakup and analysis of the aortic valve replacement market based on the product has also been provided in the report. This includes transcatheter aortic valve, sutureless valve, and others. According to the report, transcatheter aortic valve accounted for the largest market share.
Hospitals
Ambulatory Surgery Centers
Others
The report has provided a detailed breakup and analysis of the aortic valve replacement market based on the end use. This includes hospitals, ambulatory surgery centers, and others. According to the report, hospitals represented the largest segment.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for aortic valve replacement. Some of the factors driving the North America aortic valve replacement market included extensive research and development (R&D) activities, well established healthcare facilities, integration of advanced technologies, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global aortic valve replacement market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, Anteris Technologies Ltd., Boston Scientific Corporation, Coroneo Inc., CryoLife Inc., Edward Lifesciences Corporation, JenaValve Technology Inc., LifeNet Health Inc., LivaNova PLC, Medtronic plc, Thubrikar Aortic Valve Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.